Susquehanna International Group’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,970
Closed -$15.1K 14256
2022
Q4
$15.1K Buy
1,970
+1,243
+171% +$14.4K ﹤0.01% 11846
2022
Q3
$10K Buy
+727
New +$36.7K ﹤0.01% 12789
2022
Q1
Sell
-773
Closed -$188K 14637
2021
Q4
$163K Buy
773
+527
+214% +$145K ﹤0.01% 11701
2021
Q3
$80K Buy
+246
New +$76.6K ﹤0.01% 12178
2021
Q2
Sell
-213
Closed -$69.7K 13750
2021
Q1
$82K Sell
213
-163
-43% -$70.3K ﹤0.01% 11928
2020
Q4
$152K Buy
376
+105
+39% +$45.4K ﹤0.01% 10247
2020
Q3
$115K Buy
+271
New +$123K ﹤0.01% 9837
2019
Q3
Sell
-44
Closed -$18K 11189
2019
Q2
$18K Sell
44
-354
-89% -$139K ﹤0.01% 10020
2019
Q1
$126K Buy
398
+287
+259% +$124K ﹤0.01% 8154
2018
Q4
$136K Buy
+111
New +$176K ﹤0.01% 8057
2017
Q1
Sell
-29
Closed -$41K 10484
2016
Q4
$41K Buy
+29
New +$51.2K ﹤0.01% 9331

Other funds holding CFRX

Susquehanna International Group's CFRX Position: Q1 2023 in Review

Susquehanna International Group sold out of ContraFect Corporation (CFRX) in Q1 2023, closing a stake of 1,970 shares — an estimated $15.1K sold.

Susquehanna International Group first reported a position in CFRX in Q4 2016 and held it in 11 quarters. The position peaked at $163K in Q4 2021. 19 funds tracked by Wall St. Rank hold CFRX as of Q1 2023.

  • Susquehanna International Group reported no remaining ContraFect Corporation position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 1,970 ContraFect Corporation shares in Q1 2023, an estimated $15.1K.
  • Susquehanna International Group first reported a position in ContraFect Corporation in Q4 2016 and held it in 11 quarters.
  • Susquehanna International Group's ContraFect Corporation position peaked at $163K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held ContraFect Corporation as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.